Cargando…
Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
Fibrous sheath-interacting protein 1 (FSIP1) functions centrally in breast carcinogenesis and progression, although its exact role remains to be clarified. Therefore, we sought to establish a correlation between the clinico-pathological features of breast cancer and FSIP1 expression in breast cancer...
Autores principales: | Yan, Meisi, Wang, Jinsong, Ren, Yanlv, Li, Lin, He, Weidan, Zhang, Ying, Liu, Tong, Li, Zhigao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393503/ https://www.ncbi.nlm.nih.gov/pubmed/30814489 http://dx.doi.org/10.1038/s41419-018-1248-8 |
Ejemplares similares
-
LncRNA GATA3‐AS1 facilitates tumour progression and immune escape in triple‐negative breast cancer through destabilization of GATA3 but stabilization of PD‐L1
por: Zhang, Ming, et al.
Publicado: (2020) -
Expression and clinicopathological significance of FSIP1 in breast cancer
por: Zhang, Hao, et al.
Publicado: (2015) -
Bi-allelic mutation in Fsip1 impairs acrosome vesicle formation and attenuates flagellogenesis in mice
por: Gamallat, Yaser, et al.
Publicado: (2021) -
Over-expression of CDX2 alleviates breast cancer by up-regulating microRNA let-7b and inhibiting COL11A1 expression
por: Wang, Hongbin, et al.
Publicado: (2020) -
FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer
por: Yan, Xiuchun, et al.
Publicado: (2022)